Company Filing History:
Years Active: 2021-2025
Title: Allen Ebens: Innovator in Immunomodulatory Therapies
Introduction
Allen Ebens is a prominent inventor based in Seattle, WA (US), known for his contributions to the field of immunology. He holds 2 patents that focus on innovative therapies aimed at enhancing the immune response against various diseases.
Latest Patents
His latest patents include "Immunomodulatory polypeptides and related compositions and methods." This patent describes immunomodulatory polypeptides that consist of first and second subunits of a cytokine or chemokine connected by a joining region containing a targeting moiety that binds to a target molecule. The disclosure also relates to engineered cells and compositions that include these polypeptides, along with methods for their administration to subjects. In certain embodiments, the engineered cells, such as T cells, contain a genetically engineered antigen receptor that specifically binds to antigens, including chimeric antigen receptors (CAR). These innovations aim to improve the treatment of diseases by reducing adverse effects and increasing the efficacy of therapies.
Another significant patent is for "HPV-specific binding molecules." This patent provides binding molecules, such as TCRs or antigen-binding fragments, that recognize or bind to human papilloma virus (HPV) 16, including its E6 and E7 proteins. The patent also covers engineered cells containing these binding molecules, as well as methods of treatment involving their administration.
Career Highlights
Allen Ebens is currently associated with Juno Therapeutics GmbH, where he continues to work on groundbreaking research in immunotherapy. His work has significantly contributed to the advancement of treatments for various diseases, particularly in the realm of cancer therapy.
Collaborations
He collaborates with notable colleagues, including James Sissons and Cameron Brandt, who share his commitment to advancing medical science through innovative research.
Conclusion
Allen Ebens is a key figure in the development of immunomodulatory therapies, with a focus on enhancing the immune system's ability to combat diseases. His patents reflect a commitment to improving patient outcomes through innovative scientific approaches.